• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗地亚儿科医生和儿科住院医师对呼吸道合胞病毒感染的知识、态度和实践。

Knowledge, attitudes, and practices of Croatian pediatricians and pediatrics residents about RSV infection.

作者信息

Mrcela Dina, Deng Shuyu, Li You, Jukic Ivana, Markic Josko

机构信息

Department of Pediatrics, University Hospital of Split, Spinčićeva 1, Split, Croatia.

Department of Epidemiology, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, China.

出版信息

Sci Rep. 2025 May 6;15(1):15838. doi: 10.1038/s41598-025-01021-2.

DOI:10.1038/s41598-025-01021-2
PMID:40328920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12055964/
Abstract

Respiratory syncytial virus (RSV) remains a significant global health challenge, particularly for young children and the elderly. This study examines Croatian pediatricians' and pediatric residents' knowledge, attitudes, and practices regarding RSV infection and its prevention. A cross-sectional survey was conducted among members of the Croatian Pediatric Association from June to August 2023. The survey included demographic data, knowledge about RSV, risk perception across age groups, and attitudes toward RSV vaccines and monoclonal antibodies (mAbs). Logistic regression analyses were conducted to identify factors influencing knowledge, attitudes, and practice outcomes. A total of 196 participants fulfilled the survey. General knowledge scores were comparable between pediatricians and residents. Pediatricians demonstrated higher risk perception for RSV in adults (OR = 4.89, 95% CI 1.91-12.54, p = 0.001). Attitudes toward RSV vaccines and mAbs were largely favorable, with prior experience in mAb use emerging as a key predictor of positive attitudes (OR = 2.10, 95% CI 1.07-4.12, p = 0.032). Regional differences were notable, with participants from Adriatic Croatia exhibiting more favorable attitudes toward mAb use than those in Pannonian Croatia (OR = 3.82, 95% CI 1.66-8.79, p = 0.002). Gender also influenced attitudes, with male physicians more likely to recognize mAb efficacy in preventing RSV infections (OR = 3.07, 95% CI 1.44-6.54, p = 0.004). The findings highlight favorable attitudes toward RSV prevention among Croatian pediatricians and residents, with variations influenced by mAb experience, regional factors, and gender. These insights emphasize the importance of targeted educational efforts to enhance the adoption of RSV preventive strategies.

摘要

呼吸道合胞病毒(RSV)仍然是一项重大的全球健康挑战,尤其是对幼儿和老年人而言。本研究调查了克罗地亚儿科医生和儿科住院医师对RSV感染及其预防的知识、态度和实践。2023年6月至8月,对克罗地亚儿科学会成员进行了一项横断面调查。该调查包括人口统计学数据、关于RSV的知识、各年龄组的风险认知以及对RSV疫苗和单克隆抗体(mAb)的态度。进行了逻辑回归分析,以确定影响知识、态度和实践结果的因素。共有196名参与者完成了调查。儿科医生和住院医师的一般知识得分相当。儿科医生对成人RSV的风险认知更高(OR = 4.89,95% CI 1.91 - 12.54,p = 0.001)。对RSV疫苗和mAb的态度总体上是积极的,使用mAb的既往经验是积极态度的关键预测因素(OR = 2.10,95% CI 1.07 - 4.12,p = 0.032)。地区差异显著,亚得里亚海克罗地亚地区的参与者对使用mAb的态度比潘诺尼亚克罗地亚地区的参与者更积极(OR = 3.82,95% CI 1.66 - 8.79,p = 0.002)。性别也影响态度,男医生更有可能认识到mAb在预防RSV感染方面的功效(OR = 3.07,95% CI 1.44 - 6.54,p = 0.004)。研究结果凸显了克罗地亚儿科医生和住院医师对RSV预防的积极态度,这些态度因mAb经验、地区因素和性别而有所不同。这些见解强调了有针对性的教育努力对于加强RSV预防策略采用的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/12055964/f4af7561e373/41598_2025_1021_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/12055964/aac3a7f6596d/41598_2025_1021_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/12055964/b3cc6e2157c7/41598_2025_1021_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/12055964/f4af7561e373/41598_2025_1021_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/12055964/aac3a7f6596d/41598_2025_1021_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/12055964/b3cc6e2157c7/41598_2025_1021_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/12055964/f4af7561e373/41598_2025_1021_Fig3_HTML.jpg

相似文献

1
Knowledge, attitudes, and practices of Croatian pediatricians and pediatrics residents about RSV infection.克罗地亚儿科医生和儿科住院医师对呼吸道合胞病毒感染的知识、态度和实践。
Sci Rep. 2025 May 6;15(1):15838. doi: 10.1038/s41598-025-01021-2.
2
Assessment of physicians' perception of pediatrics respiratory syncytial virus disease and preferences for immunization strategies in the United States.美国医生对小儿呼吸道合胞病毒疾病的认知及免疫策略偏好评估
Hum Vaccin Immunother. 2025 Dec;21(1):2498264. doi: 10.1080/21645515.2025.2498264. Epub 2025 May 7.
3
Parental knowledge about respiratory syncytial virus and attitudes toward infant immunization with monoclonal antibodies in France.法国父母对呼吸道合胞病毒的了解以及对婴儿接种单克隆抗体疫苗的态度。
Arch Pediatr. 2024 Nov;31(8):484-492. doi: 10.1016/j.arcped.2024.07.003. Epub 2024 Sep 10.
4
Knowledge, attitudes and behaviours of a sample of Italian paediatricians towards RSV and its preventive strategies: a cross-sectional study.对 RSV 及其预防策略的意大利儿科医生样本的知识、态度和行为:一项横断面研究。
Ital J Pediatr. 2024 Feb 29;50(1):35. doi: 10.1186/s13052-024-01593-1.
5
Acceptance and preference between respiratory syncytial virus vaccination during pregnancy and infant monoclonal antibody among pregnant and postpartum persons in Canada.加拿大孕妇和产后人群对孕期呼吸道合胞病毒疫苗接种与婴儿单克隆抗体的接受度和偏好。
Vaccine. 2025 Mar 19;50:126818. doi: 10.1016/j.vaccine.2025.126818. Epub 2025 Feb 6.
6
Knowledge About Respiratory Syncytial Virus and Acceptance of Infant Monoclonal Antibody for RSV and RSV Vaccination During Pregnancy.关于呼吸道合胞病毒的知识以及对婴儿呼吸道合胞病毒单克隆抗体和孕期呼吸道合胞病毒疫苗接种的接受情况。
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S162-S166. doi: 10.1097/INF.0000000000004566. Epub 2025 Feb 14.
7
Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.父母在接受 nirsevimab 免疫计划前对呼吸道合胞病毒的了解:西班牙一个自治区的免疫态度。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2357439. doi: 10.1080/21645515.2024.2357439. Epub 2024 Jun 10.
8
Respiratory syncytial virus (RSV) prevention: Perception and willingness of expectant parents in the Netherlands.呼吸道合胞病毒(RSV)预防:荷兰准父母的认知与意愿
Vaccine. 2025 Jan 12;44:126541. doi: 10.1016/j.vaccine.2024.126541. Epub 2024 Nov 30.
9
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination.与呼吸道合胞病毒疫苗接种相关的患者及社区层面特征
JAMA Netw Open. 2025 Apr 1;8(4):e252841. doi: 10.1001/jamanetworkopen.2025.2841.
10
Investigating parental perceptions of respiratory syncytial virus (RSV) and attitudes to RSV vaccine in Jiangsu, China: Insights from a cross-section study.调查中国江苏地区家长对呼吸道合胞病毒(RSV)的认知及对RSV疫苗的态度:一项横断面研究的见解
Vaccine. 2025 Jan 12;44:126570. doi: 10.1016/j.vaccine.2024.126570. Epub 2024 Nov 29.

本文引用的文献

1
Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue.抗呼吸道合胞病毒的疫苗和治疗药物:已解决和未解决的问题
MedComm (2020). 2024 Nov 21;5(12):e70016. doi: 10.1002/mco2.70016. eCollection 2024 Dec.
2
In Brief: RSV vaccine (Arexvy) for ages 50-59.简而言之:适用于50至59岁人群的呼吸道合胞病毒疫苗(Arexvy)。
Med Lett Drugs Ther. 2024 Jul 22;66(1707):113-114. doi: 10.58347/tml.2024.1707a.
3
Parental knowledge and attitudes to infant immunization in the context of RSV: All about confidence?
父母对 RSV 背景下婴儿免疫接种的知识和态度:全都是信心的问题?
Vaccine. 2024 Oct 3;42(23):126050. doi: 10.1016/j.vaccine.2024.06.018. Epub 2024 Jun 19.
4
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.mRNA-1345 RSV 疫苗在老年人中的体液免疫原性。
J Infect Dis. 2024 Nov 15;230(5):e996-e1006. doi: 10.1093/infdis/jiae316.
5
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.尼赛珠单抗在西班牙加利西亚为婴儿进行普遍预防对呼吸道合胞病毒住院治疗的效果和影响:一项基于人群的纵向研究的初步结果。
Lancet Infect Dis. 2024 Aug;24(8):817-828. doi: 10.1016/S1473-3099(24)00215-9. Epub 2024 Apr 30.
6
Nirsevimab: A Review.尼赛珠单抗:综述。
Pediatr Allergy Immunol Pulmonol. 2024 Mar;37(1):3-6. doi: 10.1089/ped.2024.0025.
7
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.2023 年 10 月至 2024 年 2 月,新疫苗监测网络对婴儿进入首个呼吸道合胞病毒季节时,尼赛珠单抗预防呼吸道合胞病毒相关住院的早期效果评估。
MMWR Morb Mortal Wkly Rep. 2024 Mar 7;73(9):209-214. doi: 10.15585/mmwr.mm7309a4.
8
Knowledge, attitudes and behaviours of a sample of Italian paediatricians towards RSV and its preventive strategies: a cross-sectional study.对 RSV 及其预防策略的意大利儿科医生样本的知识、态度和行为:一项横断面研究。
Ital J Pediatr. 2024 Feb 29;50(1):35. doi: 10.1186/s13052-024-01593-1.
9
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.2019 年导致早产儿和幼儿急性下呼吸道感染的呼吸道合胞病毒的全球疾病负担及危险因素:汇总和个体参与者数据的系统评价和荟萃分析。
Lancet. 2024 Mar 30;403(10433):1241-1253. doi: 10.1016/S0140-6736(24)00138-7. Epub 2024 Feb 14.
10
Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.2023 年 10 月至 2024 年 1 月,西班牙对婴儿呼吸道合胞病毒下呼吸道感染住院进行 nirsevimab 免疫预防的早期效果评估。
Euro Surveill. 2024 Feb;29(6). doi: 10.2807/1560-7917.ES.2024.29.6.2400046.